Medicare Enrolled

Dr. Bradley Richlin, OD

Optometrist · Beverly Hills, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
8907 WILSHIRE BLVD FL 3, Beverly Hills, CA 90211
3102765333
In practice since 2017 (8 years)
NPI: 1619404696 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Richlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Richlin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Richlin

Dr. Bradley Richlin is an optometrist in Beverly Hills, CA, with 8 years of NPI registration. Based on federal Medicare data, Dr. Richlin performed 637 Medicare services across 528 unique beneficiaries.

Between the years covered by Open Payments, Dr. Richlin received a total of $15,292 from 28 pharmaceutical and/or device companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Richlin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ Top 15% volume in CA $15,292 industry payments

Medicare Practice Summary

Medicare Utilization ↗
637
Medicare services
Top 15% in CA for optometrist
528
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~80 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
233 $90 $130
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
165 $62 $85
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
63 $31 $90
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $90 $120
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
43 $103 $155
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
24 $94 $163
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
24 $31 $55
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $57 $80
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
19 $30 $55
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.8% high complexity
6.8% medium
89.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,292
Total received (2018-2024)
Avg $2,185/year across 7 years
Top 1% in CA for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
243
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,855 (57.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,087 (26.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,350 (15.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$493
2023
$1,289
2022
$740
2021
$4,883
2020
$3,053
2019
$2,676
2018
$2,158

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$366
Tarsus Pharmaceuticals, Inc.
$40
Optos, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Johnson & Johnson Vision Care, Inc.
$22
CooperVision Inc.
$15
Top 3 companies account for 87.7% of 2024 payments
All-time payments by company (2018-2024) ›
CooperVision Inc.
$6,914
Johnson & Johnson Vision Care, Inc.
$2,758
Alcon Vision LLC
$1,611
Bausch & Lomb, a division of Bausch Health US, LLC
$614
ABB Con-Cise Optical Group LLC
$595
Shire North American Group Inc
$578
Alcon Laboratories Inc
$553
Eyevance Pharmaceuticals LLC
$243
Johnson & Johnson Surgical Vision, Inc.
$216
Allergan, Inc.
$190
ABBVIE INC.
$170
OPTOS, INC.
$129
Sight Sciences, Inc.
$115
OPTOVUE, INC.
$96
Dompe US, Inc.
$75
Glaukos Corporation
$54
Sun Pharmaceutical Industries Inc.
$52
Allergan Inc.
$49
Oyster Point Pharma, Inc.
$40
Tarsus Pharmaceuticals, Inc.
$40
Horizon Therapeutics plc
$36
EYEVANCE PHARMACEUTICALS LLC
$34
Visioneering Technologies, Inc.
$28
Optos, Inc.
$26
Novartis Pharmaceuticals Corporation
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
BIOTISSUE HOLDINGS, INC.
$15
Spark Therapeutics, Inc.
$12
Top 3 companies account for 73.8% of all-time payments
Associated products mentioned in payments ›
AIR OPTIX · Acuvue · BIOTRUE · BIOTRUE ONE DAY · CEQUA · Centurion · Cequa · Clareon · Clariti Contact Lens · Contact Lens · DAILIES · DAILIES TOTAL1 · Flarex · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · LUXTURNA · MARLO · Multiple Brands Contact Lens · MyDay Contact Lens · NFC-700 · OXERVATE · Onefit Contact Lens · P200DTx · PROKERA · PROLENSA · Precision 1 · RESTASIS MULTIDOSE · TEPEZZA · TOTAL30 · TYRVAYA · TearCare · TearScience Activators · TobraDex ST · Tobradex ST · VUITY · VYZULTA · XDEMVY · XIIDRA · XR · Zerviate · iStent inject Trabecular Micro-Bypass Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for optometrist in CA.

Looking for an optometrist in Beverly Hills?
Compare optometrists in the Beverly Hills area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
1,709
Per 100K population
17.4
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Richlin is a mixed practice specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 1% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Richlin experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Richlin performed 233 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Richlin receive payments from pharmaceutical companies?
Yes. Dr. Richlin received a total of $15,292 from 28 companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Richlin's costs compare to other optometrists in Beverly Hills?
Dr. Richlin's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Richlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →